Milestone Scientific acquires additional patent rights for painless injections
Milestone Scientific Inc., a leader in advanced injection technologies, has announced it has acquired additional patent rights with respect to painless anesthetic injections.
Pain Therapeutics, Inc., a biopharmaceutical company, has received a $5 million milestone payment from King Pharmaceuticals, Inc., its exclusive commercial partner for abuse-resistant prescription pain medications.